Concomitant detection of BCR-ABL translocation and JAK2 V617F mutation in five patients with myeloproliferative neoplasm at diagnosis

被引：8
|
作者：
Cappetta, M. [1 ,2 ]
Perez, V. [1 ]
Zubillaga, M. N. [1 ]
Elizondo, V. [1 ]
Manrique, G. [1 ]
Prosper, I. [3 ]
Boschi, S. [1 ]
Bonomi, R. [3 ]
Pomoli, S. [4 ]
Diaz, L. [5 ]
Martinez, L. [6 ]
Uriarte, M. R. [1 ]
机构：
[1] Asociac Espanola Primera Socorros Mutuos, Specialized Tech Lab, Div Mol Biol, Montevideo, Uruguay
[2] Univ Republica, Dept Genet, Sch Med, Montevideo, Uruguay
[3] Asociac Espanola Primera Socorros Mutuos, Specialized Tech Lab, Cytogenet Div, Montevideo, Uruguay
[4] Hosp Cent Fuerzas Armadas, Hematol Serv, Montevideo, Uruguay
[5] GREMCA, Hematol Serv, Montevideo, Uruguay
[6] Asociac Espanola Primera Socorros Mutuos, Specialized Tech Lab, Div Hematol, Montevideo, Uruguay
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2013年 / 35卷 / 01期
关键词：
CHRONIC MYELOID-LEUKEMIA;
D O I：
10.1111/ijlh.12010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [41] Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation
    Xu, Weiyi
    Chen, Baode
    Tong, Xiangmin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (01) : 87 - 90
  • [42] Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation
    Weiyi Xu
    Baode Chen
    Xiangmin Tong
    International Journal of Hematology, 2014, 99 : 87 - 90
  • [43] Clonal Competition Between JAK2 and BCR-ABL in Myeloproliferative Neoplasm
    Salk, Gabriel
    Mangala, Yashvin Onkarappa
    Onukogu, Ifeanyichukwu David
    Meleveedu, Kapil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S384 - S384
  • [44] The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods
    Lucia, Eugenio
    Martino, Bruno
    Mammi, Corrado
    Vigna, Ernesto
    Mazzone, Carla
    Gentile, Massimo
    Qualtieri, Gabriele
    Bisconte, Maria Grazia
    Naccarato, Maria
    Gentile, Carlo
    Lagana, Carmelo
    Romeo, Francesco
    Neri, Antonino
    Nobile, Francesco
    Morabito, Fortunato
    LEUKEMIA & LYMPHOMA, 2008, 49 (10) : 1907 - 1915
  • [45] THE MUTATION LEVEL OF JAK2 V617F STRONGLY CORRELATED WITH VASCULAR EVENTS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASM
    Bang, S. M.
    Lee, J. S.
    Ahn, J. Y.
    Lee, J. H.
    Hyun, M. S.
    Kim, B. S.
    Park, M. R.
    Chi, H. S.
    Kim, H. Y.
    Kim, H. J.
    Lee, M. H.
    Kim, H.
    Won, J. H.
    Yoon, H. J.
    Oh, D.
    Nam, E. M.
    Bae, S. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 303 - 303
  • [46] Co-existing BCR-ABL translocation and JAK2V617F mutation in a patient with chronic myeloproliferative disease
    Hussein, K.
    Seegers, A.
    Buhr, T.
    Buesche, G.
    Kreipe, H.
    Bock, O.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 392 - 393
  • [47] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR
    Waterhouse, M.
    Pfeifer, D.
    Follo, M.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [48] Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation
    Hussein, K.
    Bock, O.
    Theophile, K.
    Seegers, A.
    Arps, H.
    Basten, O.
    Grips, K-H
    Franz-Werner, J.
    Buesche, R.
    Kreipe, H.
    LEUKEMIA, 2008, 22 (05) : 1059 - 1062
  • [49] The JAK2 V617F mutation in patients with anaemia
    S. E. Langabeer
    Irish Journal of Medical Science (1971 -), 2017, 186 : 349 - 350
  • [50] JAK2 V617F Genetic Biomarker Used in Differential Diagnosis for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Talmaci, Rodica
    Cucu, Natalia
    Dragomir, Mihaela
    Aposteanu, Silvia
    Coriu, D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S356 - S357
12345